Form 4: Biote Corp. Director Stephen Mark Cone Reports Acquisition of Stock Options and RSUs

Director Stephen Mark Cone reports acquisition of stock options and restricted stock units (RSUs) in Biote Corp.

Summary

• On May 13, 2025, Stephen Mark Cone, a director of Biote Corp., reported acquiring 104,547 stock options with an exercise price of $3.91, and 17,989 Deferred Settlement RSUs.
• The RSUs are fully vested upon grant but will be settled upon separation from service.
• The stock options vest on the earlier of May 13, 2026, or the day prior to the Issuer's 2026 Annual Meeting of Stockholders, contingent upon continuous service.
• Following these transactions, Cone directly owns 38,341 derivative securities and 104,547 stock options.

Sentiment

Score: 6

Explanation: The sentiment is neutral as it's a standard regulatory filing. The acquisition of shares by a director can be seen as a positive sign, but it's not overwhelmingly so.

Positives

• The acquisition of stock options and RSUs by a director signals confidence in the company's future performance.

Industry Context

This filing is a routine disclosure related to insider transactions, common in publicly traded companies. It provides transparency into the actions of company insiders.

Stakeholder Impact

• The acquisition of stock options and RSUs by a director may have a slightly positive impact on shareholder sentiment.

Key Dates

Keywords

Form 4, Beneficial Ownership, Stock Options, Restricted Stock Units, Director, Biote Corp, BTMD, Stephen Mark Cone